Skip to main content
. 2021 Jul 15;28:53. doi: 10.1186/s12929-021-00749-z

Table 2.

Primer sequence

Gene Primer sequence
miR-381 F: 5′ TGGTACTTAAAGCGAGGTTGC 3′
R: 5′ GGTCATGCACACACATACCAC 3′
U6 F: 5′ CTCGCTTCGGCAGCACATATACT 3′
R: 5′ ACGCTTCACGAATTTGCGTGTC 3′
NEAT1 F: 5′ TGGCTAGCTCAGGGCTTCAG 3′
R: 5′ TCTCCTTGCCAAGCTTCCTTC 3′
IGF1 F: 5′ CTCTTTCTACCTGGCGCTCTG 3′
R: 5′ GCAACACTCATCCACAATGC3′
PCNA F: 5′ GATGTTCCTCTCGTTGTGGAG3′
R: 5′ CATTGCAGTTAAGAGCCTTCC3′
Cyclin D1 F: 5′ AGCTGAGGCGTCCCAACC 3′
R: 5′ CAACCAGAATACACAAAGCCAACC 3′
Caspase-3 F: 5′ GACTAGCTTTCTTCAGAGGCGA 3′
R: 5′ ATTCCGTTGCCACCTTCCTG3′
Bax F: 5′ CTGCAGAGGATGATTGCTGA 3′
R: 5′ GATCAGCTCGGGCACTTTAG 3′
Bcl-2 F: 5′ CGACTTTGCAGAGATGTCCA3′
R: 5′ ATGCCGGTTCAGGTACTCAG3′
GAPDH F: 5′ ACGGCAAGTTCAACGGCACAG 3′
R: 5′ GACGCCAGTAGACTCCACGACA 3′

F forward, R reverse, MiR-381 microRNA-381, IGF1 insulin-like growth factors-1, PCNA proliferating cell nuclear antigen, Bax B-cell lymphoma 2-associated X, Bcl-2 B-cell lymphoma 2, GAPDH glyceraldehyde-3-phosphate dehydrogenase